nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2B6—Ifosfamide—testicular cancer	0.126	0.186	CbGbCtD
Fosphenytoin—CYP2C8—Ifosfamide—testicular cancer	0.0957	0.141	CbGbCtD
Fosphenytoin—CYP2C19—Ifosfamide—testicular cancer	0.0803	0.118	CbGbCtD
Fosphenytoin—CYP2C9—Ifosfamide—testicular cancer	0.0668	0.0982	CbGbCtD
Fosphenytoin—CYP2B6—Cisplatin—testicular cancer	0.0615	0.0904	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—testicular cancer	0.0458	0.0673	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—testicular cancer	0.0412	0.0606	CbGbCtD
Fosphenytoin—ALB—Methotrexate—testicular cancer	0.0391	0.0575	CbGbCtD
Fosphenytoin—CYP3A4—Ifosfamide—testicular cancer	0.0388	0.0571	CbGbCtD
Fosphenytoin—CYP2C9—Cisplatin—testicular cancer	0.0325	0.0478	CbGbCtD
Fosphenytoin—CYP3A4—Vinblastine—testicular cancer	0.0206	0.0303	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—testicular cancer	0.0186	0.0273	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—testicular cancer	0.0127	0.0186	CbGbCtD
Fosphenytoin—Body temperature increased—Ifosfamide—testicular cancer	0.00028	0.000873	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Etoposide—testicular cancer	0.000279	0.000873	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—testicular cancer	0.000279	0.000872	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000278	0.000868	CcSEcCtD
Fosphenytoin—Infection—Etoposide—testicular cancer	0.000277	0.000867	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—testicular cancer	0.000277	0.000866	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—testicular cancer	0.000277	0.000865	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—testicular cancer	0.000275	0.00086	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—testicular cancer	0.000275	0.00086	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—testicular cancer	0.000275	0.00086	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—testicular cancer	0.000275	0.00086	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—testicular cancer	0.000274	0.000856	CcSEcCtD
Fosphenytoin—Paraesthesia—Cisplatin—testicular cancer	0.000274	0.000855	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—testicular cancer	0.000273	0.000854	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—testicular cancer	0.000273	0.000852	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—testicular cancer	0.000272	0.00085	CcSEcCtD
Fosphenytoin—Dyspnoea—Cisplatin—testicular cancer	0.000272	0.000849	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—testicular cancer	0.00027	0.000844	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000269	0.000841	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—testicular cancer	0.000269	0.000839	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—testicular cancer	0.000268	0.000838	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—testicular cancer	0.000266	0.000832	CcSEcCtD
Fosphenytoin—Decreased appetite—Cisplatin—testicular cancer	0.000265	0.000828	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—testicular cancer	0.000265	0.000827	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—testicular cancer	0.000264	0.000825	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—testicular cancer	0.000264	0.000824	CcSEcCtD
Fosphenytoin—Vomiting—Bleomycin—testicular cancer	0.000263	0.000822	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—testicular cancer	0.000261	0.000815	CcSEcCtD
Fosphenytoin—Rash—Bleomycin—testicular cancer	0.000261	0.000815	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—testicular cancer	0.000261	0.000815	CcSEcCtD
Fosphenytoin—Dermatitis—Bleomycin—testicular cancer	0.000261	0.000814	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—testicular cancer	0.00026	0.000812	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—testicular cancer	0.000258	0.000806	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—testicular cancer	0.000257	0.000804	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—testicular cancer	0.000255	0.000797	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—testicular cancer	0.000255	0.000796	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—testicular cancer	0.000255	0.000796	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—testicular cancer	0.000255	0.000796	CcSEcCtD
Fosphenytoin—Asthenia—Ifosfamide—testicular cancer	0.000254	0.000793	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—testicular cancer	0.000251	0.000786	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000251	0.000785	CcSEcCtD
Fosphenytoin—Feeling abnormal—Cisplatin—testicular cancer	0.000251	0.000785	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—testicular cancer	0.000251	0.000784	CcSEcCtD
Fosphenytoin—Pruritus—Ifosfamide—testicular cancer	0.00025	0.000782	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—testicular cancer	0.000249	0.000778	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—testicular cancer	0.000248	0.000776	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—testicular cancer	0.000248	0.000776	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—testicular cancer	0.000247	0.000773	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—testicular cancer	0.000247	0.000771	CcSEcCtD
Fosphenytoin—Nausea—Bleomycin—testicular cancer	0.000246	0.000768	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—testicular cancer	0.000245	0.000767	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—testicular cancer	0.000245	0.000765	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—testicular cancer	0.000243	0.00076	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—testicular cancer	0.000243	0.000759	CcSEcCtD
Fosphenytoin—Diarrhoea—Ifosfamide—testicular cancer	0.000242	0.000756	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—testicular cancer	0.000241	0.000754	CcSEcCtD
Fosphenytoin—Body temperature increased—Cisplatin—testicular cancer	0.000241	0.000753	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—testicular cancer	0.000239	0.000746	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—testicular cancer	0.000239	0.000746	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—testicular cancer	0.000238	0.000744	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—testicular cancer	0.000235	0.000735	CcSEcCtD
Fosphenytoin—Dizziness—Ifosfamide—testicular cancer	0.000234	0.000731	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—testicular cancer	0.000234	0.00073	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000233	0.000727	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—testicular cancer	0.000232	0.000723	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—testicular cancer	0.00023	0.00072	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—testicular cancer	0.00023	0.000719	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—testicular cancer	0.00023	0.000718	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—testicular cancer	0.000229	0.000716	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—testicular cancer	0.000228	0.000714	CcSEcCtD
Fosphenytoin—Vomiting—Ifosfamide—testicular cancer	0.000225	0.000703	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—testicular cancer	0.000224	0.000701	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—testicular cancer	0.000223	0.000698	CcSEcCtD
Fosphenytoin—Rash—Ifosfamide—testicular cancer	0.000223	0.000697	CcSEcCtD
Fosphenytoin—Dermatitis—Ifosfamide—testicular cancer	0.000223	0.000696	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—testicular cancer	0.000222	0.000693	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—testicular cancer	0.000221	0.00069	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—testicular cancer	0.000221	0.00069	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—testicular cancer	0.000221	0.00069	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—testicular cancer	0.00022	0.000686	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—testicular cancer	0.000219	0.000685	CcSEcCtD
Fosphenytoin—Asthenia—Cisplatin—testicular cancer	0.000219	0.000683	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—testicular cancer	0.000219	0.000683	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—testicular cancer	0.000218	0.00068	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—testicular cancer	0.000214	0.000669	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—testicular cancer	0.000213	0.000666	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—testicular cancer	0.000211	0.00066	CcSEcCtD
Fosphenytoin—Nausea—Ifosfamide—testicular cancer	0.00021	0.000656	CcSEcCtD
Fosphenytoin—Diarrhoea—Cisplatin—testicular cancer	0.000209	0.000652	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—testicular cancer	0.000208	0.000649	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—testicular cancer	0.000205	0.000642	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—testicular cancer	0.000204	0.000639	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000203	0.000634	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—testicular cancer	0.000202	0.000632	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—testicular cancer	0.000201	0.000627	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—testicular cancer	0.0002	0.000626	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—testicular cancer	0.000198	0.00062	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—testicular cancer	0.000198	0.000618	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—testicular cancer	0.000198	0.000617	CcSEcCtD
Fosphenytoin—Vomiting—Cisplatin—testicular cancer	0.000194	0.000606	CcSEcCtD
Fosphenytoin—Rash—Cisplatin—testicular cancer	0.000192	0.000601	CcSEcCtD
Fosphenytoin—Dermatitis—Cisplatin—testicular cancer	0.000192	0.0006	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—testicular cancer	0.000191	0.000597	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—testicular cancer	0.00019	0.000594	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—testicular cancer	0.00019	0.000594	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—testicular cancer	0.000189	0.000592	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—testicular cancer	0.000189	0.000591	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—testicular cancer	0.000188	0.000588	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—testicular cancer	0.000188	0.000587	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—testicular cancer	0.000186	0.000582	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—testicular cancer	0.000186	0.00058	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—testicular cancer	0.000185	0.000578	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—testicular cancer	0.000185	0.000577	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—testicular cancer	0.000184	0.000576	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—testicular cancer	0.000184	0.000575	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—testicular cancer	0.000183	0.000573	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—testicular cancer	0.000183	0.000572	CcSEcCtD
Fosphenytoin—Nausea—Cisplatin—testicular cancer	0.000181	0.000566	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—testicular cancer	0.000179	0.000559	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—testicular cancer	0.000178	0.000556	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—testicular cancer	0.000178	0.000555	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—testicular cancer	0.000178	0.000555	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—testicular cancer	0.000177	0.000554	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—testicular cancer	0.000176	0.000551	CcSEcCtD
Fosphenytoin—Rash—Etoposide—testicular cancer	0.000176	0.00055	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—testicular cancer	0.000176	0.00055	CcSEcCtD
Fosphenytoin—Headache—Etoposide—testicular cancer	0.000175	0.000547	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—testicular cancer	0.000175	0.000546	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—testicular cancer	0.000175	0.000545	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—testicular cancer	0.000175	0.000545	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—testicular cancer	0.000174	0.000544	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—testicular cancer	0.000174	0.000543	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—testicular cancer	0.000173	0.000541	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—testicular cancer	0.000172	0.000539	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—testicular cancer	0.000172	0.000539	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—testicular cancer	0.000172	0.000539	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—testicular cancer	0.000172	0.000538	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—testicular cancer	0.000172	0.000537	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—testicular cancer	0.000172	0.000536	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—testicular cancer	0.000171	0.000533	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—testicular cancer	0.00017	0.00053	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—testicular cancer	0.000169	0.000527	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—testicular cancer	0.000169	0.000527	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—testicular cancer	0.000167	0.000523	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—testicular cancer	0.000167	0.000523	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—testicular cancer	0.000166	0.000519	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—testicular cancer	0.000166	0.000519	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—testicular cancer	0.000166	0.000518	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—testicular cancer	0.000166	0.000517	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000165	0.000515	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—testicular cancer	0.000164	0.000513	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—testicular cancer	0.000164	0.000512	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—testicular cancer	0.000163	0.00051	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—testicular cancer	0.000163	0.00051	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—testicular cancer	0.000163	0.00051	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—testicular cancer	0.000162	0.000505	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—testicular cancer	0.000161	0.000504	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—testicular cancer	0.00016	0.0005	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—testicular cancer	0.00016	0.000499	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—testicular cancer	0.000159	0.000498	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—testicular cancer	0.000159	0.000498	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—testicular cancer	0.000159	0.000497	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—testicular cancer	0.000159	0.000496	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—testicular cancer	0.000158	0.000493	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—testicular cancer	0.000157	0.00049	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—testicular cancer	0.000157	0.000489	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—testicular cancer	0.000156	0.000488	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—testicular cancer	0.000156	0.000487	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—testicular cancer	0.000156	0.000486	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—testicular cancer	0.000155	0.000484	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—testicular cancer	0.000154	0.000481	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—testicular cancer	0.000154	0.000481	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—testicular cancer	0.000153	0.000479	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—testicular cancer	0.000153	0.000479	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—testicular cancer	0.000153	0.000477	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000152	0.000476	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—testicular cancer	0.000151	0.000473	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—testicular cancer	0.000151	0.000473	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—testicular cancer	0.000151	0.000472	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—testicular cancer	0.000151	0.000472	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—testicular cancer	0.00015	0.000469	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—testicular cancer	0.000149	0.000467	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—testicular cancer	0.000149	0.000466	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—testicular cancer	0.000149	0.000466	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—testicular cancer	0.000149	0.000465	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—testicular cancer	0.000148	0.000462	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—testicular cancer	0.000147	0.00046	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—testicular cancer	0.000146	0.000457	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—testicular cancer	0.000146	0.000456	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—testicular cancer	0.000145	0.000454	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000145	0.000453	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—testicular cancer	0.000144	0.00045	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000143	0.000446	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—testicular cancer	0.000143	0.000445	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000142	0.000443	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—testicular cancer	0.000142	0.000442	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—testicular cancer	0.000141	0.000442	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—testicular cancer	0.000141	0.000439	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—testicular cancer	0.00014	0.000438	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—testicular cancer	0.00014	0.000436	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—testicular cancer	0.000139	0.000435	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—testicular cancer	0.000138	0.000431	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—testicular cancer	0.000138	0.000431	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—testicular cancer	0.000138	0.000431	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—testicular cancer	0.000136	0.000425	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—testicular cancer	0.000135	0.000423	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—testicular cancer	0.000134	0.000418	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—testicular cancer	0.000133	0.000415	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—testicular cancer	0.000132	0.000413	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000132	0.000412	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—testicular cancer	0.000131	0.000409	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—testicular cancer	0.00013	0.000406	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—testicular cancer	0.000129	0.000404	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—testicular cancer	0.000129	0.000403	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—testicular cancer	0.000129	0.000402	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—testicular cancer	0.000128	0.000398	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—testicular cancer	0.000126	0.000393	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—testicular cancer	0.000124	0.000389	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—testicular cancer	0.000124	0.000387	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—testicular cancer	0.000124	0.000387	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—testicular cancer	0.00012	0.000375	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—testicular cancer	0.000119	0.000373	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—testicular cancer	0.000118	0.00037	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—testicular cancer	0.000115	0.00036	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—testicular cancer	0.000115	0.000358	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—testicular cancer	0.000114	0.000358	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—testicular cancer	0.000112	0.000351	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—testicular cancer	0.000111	0.000346	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—testicular cancer	0.000111	0.000346	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—testicular cancer	0.000107	0.000335	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—testicular cancer	0.000106	0.000332	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—testicular cancer	0.000105	0.00033	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—testicular cancer	0.000105	0.000329	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—testicular cancer	0.000105	0.000327	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—testicular cancer	0.000104	0.000325	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—testicular cancer	0.000104	0.000323	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—testicular cancer	0.000102	0.00032	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—testicular cancer	9.95e-05	0.000311	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—testicular cancer	9.94e-05	0.00031	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—testicular cancer	9.91e-05	0.00031	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—testicular cancer	9.87e-05	0.000308	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—testicular cancer	9.86e-05	0.000308	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—testicular cancer	9.81e-05	0.000306	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—testicular cancer	9.58e-05	0.000299	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—testicular cancer	9.3e-05	0.000291	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—testicular cancer	9.21e-05	0.000288	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—testicular cancer	9.13e-05	0.000285	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—testicular cancer	9.13e-05	0.000285	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—testicular cancer	9.08e-05	0.000284	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—testicular cancer	8.6e-05	0.000269	CcSEcCtD
